Vivani Medical Reports First Quarter Financial Results and Provides Business UpdateBusiness Wire • 05/15/23
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent's Ongoing Orion Clinical StudyBusiness Wire • 04/04/23
Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateBusiness Wire • 03/31/23
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation DivisionBusiness Wire • 03/21/23
Vivani Medical Reports Third Quarter 2022 Results and Provides Business UpdatesBusiness Wire • 11/14/22